SL

Shaoling Li

TI Theravance Biopharma R&D Ip: 3 patents #64 of 116Top 60%
AL Alza: 1 patents #287 of 419Top 70%
NU Nanjing University: 1 patents #249 of 887Top 30%
RM Revolution Medicines: 1 patents #46 of 61Top 80%
📍 Sunnyvale, CA: #4,180 of 14,302 inventorsTop 30%
🗺 California: #93,399 of 386,348 inventorsTop 25%
Overall (All Time): #813,295 of 4,157,543Top 20%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11452723 Combination dosage form of a mu opioid receptor antagonist and an opioid agent Manshiu Leung, Hao Zhang, Venkat R. Thalladi, Yun Mo 2022-09-27
11220501 Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8- azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl} methanol, a SHP2 inhibitor Steven G. BALLMER 2022-01-11
10946009 Combination dosage form of a mu opioid receptor antagonist and an opioid agent Manshiu Leung, Hao Zhang, Venkat R. Thalladi, Yun Mo 2021-03-16
10369142 Combination dosage form of a mu opioid receptor antagonist and an opioid agent Manshiu Leung, Hao Zhang, Venkat R. Thalladi, Yun Mo 2019-08-06
9066870 Methods for drug delivery comprising unfolding and folding proteins and peptide nanoparticles Yiqiao Hu, Jinhui Wu, Dawei Ding, Guangming Gong, Xiaolei Tang +2 more 2015-06-30
7338663 Expandable osmotic composition and coating suspension Liang Dong, Padmaja Shivanand, Patrick S. L. Wong 2008-03-04